Non-pharmaceutical Motion Sickness Mitigation

Non-pharmaceutical Motion Sickness Mitigation

The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.

Inclusion Criteria:

• Must be able to consent to participate themselves.
• Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
• No racial ethnic groups will be excluded.
• Must be fluent speakers of English.

Exclusion Criteria:

• History of vestibular disease, migraine, or significant balance disorder.
• Traumatic brain injury.
• Recent middle ear infection or recent motion sickness (within 72 hours).
• History of severe motion sensitivity.
• Women who are pregnant.